Clinical Trials Sponsored by MEI Pharma, Inc.
Total 2468 results
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States
-
Darma Inc.Virginia Commonwealth UniversityCompletedVital Sign MonitoringUnited States
-
University of ManitobaWinnipeg Regional Health Authority; MED XL IncCompletedBacteremia | Catheter Related InfectionCanada
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
National Eye Institute (NEI)The Emmes Company, LLC; Santen Inc.TerminatedGeographic AtrophyUnited States
-
Faes Farma, S.A.ORA, Inc.CompletedAllergic ConjunctivitisUnited States
-
Universidad de los Andes, ChileGeistlich Pharma AG; BioHorizons, Inc.RecruitingAlveolar Ridge EnlargementChile
-
University of Illinois at ChicagoMitsubishi Tanabe Pharma America Inc.RecruitingAmyotrophic Lateral SclerosisUnited States
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.Oyster Point Pharma, Inc.Completed
-
Enyo PharmaParexel; Novotech (Australia) Pty Limited; Synteract, Inc.; EurofinsTerminatedHepatitis B, ChronicAustralia, Hong Kong, Korea, Republic of, Poland
-
MEDA Pharma GmbH & Co. KGSanofi; ClinResearch, GmbHCompletedAsthma, Exercise-InducedGermany
-
Teva Pharma GmbHCompleted
-
EIP Pharma IncAmsterdam UMC, location VUmc; Worldwide Clinical TrialsCompletedAlzheimer DiseaseUnited States, Netherlands, United Kingdom, Czechia, Denmark
-
University of Texas Southwestern Medical CenterAstellas Pharma US, Inc.CompletedProstate CancerUnited States
-
US Oncology ResearchBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedColorectal Neoplasms | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
Institut für Pharmakologie und Präventive MedizinPharma Medica Research, Inc.CompletedFever | Pain, Acute | Pain, Back | Pain, HeadCanada
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedneurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade GliomaUnited States
-
Norman MuirheadAstellas Pharma Canada, Inc.Completed
-
Faes Farma, S.A.ORA, Inc.CompletedAllergic ConjunctivitisUnited States
-
Darma Inc.Tufts Medical CenterCompletedVital Sign MonitoringUnited States
-
Institut de Recherches Cliniques de MontrealPharmascience Inc.; SCiAN Services, Inc.; Quercis Pharma AGNot yet recruiting
-
Sawa Ito, MDHorizon Pharma USA, Inc.CompletedMyelodysplastic Syndromes | Myeloid Leukemia | Allogeneic Stem Cell TransplantationUnited States
-
EA Pharma Co., Ltd.Kissei Pharmaceutical Co., Ltd.CompletedA Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative ColitisColitis, UlcerativeJapan
-
Cleveland Clinic FloridaAstellas Pharma US, Inc.Terminated
-
Teva Pharma GmbHCompletedPatient SatisfactionGermany
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Linical KoreaNational Cancer Center, Korea; Astellas Pharma Korea, Inc.Completed
-
Radboud University Medical CenterAstellas Pharma Inc; St. Antonius HospitalCompleted
-
Ranjan DohilMeritage Pharma, Inc.CompletedEosinophilic EsophagitisUnited States
-
St. Louis UniversityAstellas Pharma US, Inc.; University of FloridaCompletedCoronary Artery DiseaseUnited States
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
AZTherapies, Inc.Pharma Consulting Group AB; KCAS; Panax Clinical ResearchCompletedHealthy VolunteersUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
University of WashingtonBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedHepatocellular Carcinoma
-
Aneira Pharma, Inc.DataPharm Australia, CMAX Clinical Research, Agilex AustraliaNot yet recruiting
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
University of Michigan Rogel Cancer CenterAscentage Pharma Group Inc.Active, not recruitingSalivary Gland Cancer | Malignant Salivary Gland CancerUnited States
-
Attune Health Research, Inc.Horizon Pharma Ireland, Ltd., Dublin IrelandActive, not recruiting
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
University of North Carolina, Chapel HillAstellas Pharma US, Inc.Completed
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.Oyster Point Pharma, Inc.Completed
-
Tris Pharma, Inc.Massachusetts General Hospital; Massachusetts Institute of TechnologyCompleted
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed
-
University of Texas Southwestern Medical CenterAstellas Pharma US, Inc.CompletedObesity | Nutrition Disorders | OverweightUnited States
-
State University of New York at BuffaloAstellas Pharma IncWithdrawnUrinary Frequency/Urgency | Bladder Pain Syndrome | Bladder IrritableUnited States
-
Sucampo Pharma Americas, LLCSucampo AG; Sucampo Pharmaceuticals, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedUrinary Bladder, OveractiveKorea, Republic of
-
Derm Research, PLLCBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedAcne RosaceaUnited States